Article info
Recommendation
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
- Correspondence to Professor Daniel Aletaha, Division of Rheumatology, Medical University of Vienna, Wien 1090, Austria; daniel.aletaha{at}meduniwien.ac.at
Citation
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
Publication history
- Received May 12, 2022
- Accepted July 18, 2022
- First published August 11, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (11 May 2023).
- Previous version (11 May 2023).
- Previous version (11 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.